Core Viewpoint - Liou Group Co., Ltd. has submitted an application for the issuance and listing of overseas shares (H shares) on the Hong Kong Stock Exchange, aiming for a public listing on the main board [1][2]. Group 1 - The application was submitted on September 29, 2025, and the related materials have been published on the Hong Kong Stock Exchange website [1]. - The subscription for this issuance is limited to qualified overseas investors and domestic qualified investors who are authorized to conduct overseas securities investments under Chinese laws [2]. - The company will not publish the application materials on domestic stock exchange websites or media that meet domestic regulatory conditions [2]. Group 2 - The issuance and listing are subject to approvals or filings from relevant government departments, regulatory agencies, and stock exchanges, indicating potential uncertainties [3]. - The company commits to timely information disclosure in accordance with relevant laws and regulations as the situation progresses [3].

Core Viewpoint - Liou Group Co., Ltd. (Liou Shares) is focusing on AI-driven digital marketing and smart pump systems, with plans to enhance investments in AI computing infrastructure [4]. Business Overview - Liou Shares was established in 2001, with two main business segments: mechanical manufacturing and digital marketing. The mechanical manufacturing segment focuses on the research, development, and sales of civil pumps, industrial pumps, and garden machinery. The digital marketing segment offers a complete service chain covering marketing strategy, media placement, performance monitoring, and social marketing [3][4]. Financial Performance - In the first half of the year, Liou Shares achieved operating revenue of 9.635 billion yuan, a decrease of 9.62% year-on-year. The net profit attributable to shareholders was 478 million yuan, an increase of 164.28% year-on-year. The net profit after deducting non-recurring gains and losses was 148 million yuan, up 1.88% year-on-year [5]. - The mechanical manufacturing segment generated operating revenue of 2.131 billion yuan, while the digital marketing segment contributed 7.477 billion yuan [3]. AI and Technology Development - The company has launched a new smart liquid cooling system called "Smart Cooling Solution," which covers all application scenarios in data centers, integrating single pump products, integrated pump rooms, supporting services, and smart operation systems to help data centers achieve energy savings [5]. - In the AI application layer, the company has developed a dedicated AI intelligent agent matrix covering strategy formulation, creative production, placement, and operation, achieving intelligent upgrades across the marketing chain [6]. Future Investment Plans - Liou Shares plans to raise funds for investments in AI infrastructure, including the development of overseas AI computing centers and domestic computing and R&D centers. The company aims to participate in the development of overseas AI computing centers through special funds or direct equity investments [6]. - The company also plans to rent industry-leading AI models and procure or lease high-performance computing and network equipment to support R&D innovation [6].

Core Insights - Liou Co., Ltd. is advancing its capital structure optimization and international market integration by applying for a listing on the Hong Kong Stock Exchange, focusing on its dual core businesses of AI digital marketing and smart pumps and systems [1] Group 1: AI Digital Marketing - The AI digital marketing sector is experiencing explosive growth driven by the deepening of the digital economy and advancements in AI technology, positioning Liou Co., Ltd. as a leading player in the domestic market [2] - Liou Co., Ltd.'s AI digital marketing business has achieved the largest revenue scale in China's digital marketing market and has consistently ranked first in the China Academy of Sciences' digital marketing company rankings [2] - The company has developed proprietary models such as "LEOAIAD" and "Liou Unified," embedding them into various marketing workflows to enhance data acquisition and profitability [2] Group 2: Smart Pumps and Systems - Liou Co., Ltd. ranks second in China's pump and system industry and thirteenth globally based on projected 2024 revenue, while being the top exporter in the domestic civil pump sector [3] - The company is innovating in key components like motors and controllers, enhancing its product offerings and creating comprehensive solutions in smart pumps and systems [3] - The liquid cooling market, driven by the surge in data center computing power demand, is projected to grow at a compound annual growth rate of over 32.4% from 2024 to 2029, with liquid cooling pumps expected to grow at 31.8% [4] Group 3: Strategic Initiatives - The listing on the Hong Kong Stock Exchange is a strategic move to enhance the dual core business model, with funds aimed at AI infrastructure, manufacturing technology R&D, and global expansion [4] - The integration of AI technology into smart pumps and systems is expected to position Liou Co., Ltd. as a leading benchmark in the industry, leveraging technological advantages and cost control [4]

Group 1: Industry Overview - The export value of China's agricultural machinery is significantly higher than its import value, with exports projected to reach 15.93 billion yuan in 2024, a year-on-year increase of 11.9%, while imports are expected to be 3.25 billion yuan, up 2.8% [2] - India is the largest export destination for Chinese agricultural machinery, with exports to India, Russia, Thailand, and the United States collectively accounting for 30% of total exports in 2024 [2] Group 2: Policy Support - National policies supporting the agricultural machinery industry include the "14th Five-Year" National Agricultural Mechanization Development Plan and the Digital Rural Development Action Plan (2022-2025), focusing on enhancing mechanization rates and developing smart agricultural equipment [7][8] - Key policy goals include increasing the comprehensive mechanization rate of crop farming to 75% by 2025 and ensuring that major agricultural machinery products achieve international advanced quality standards [9][10] Group 3: Regional Development Goals - Various provinces have set specific agricultural machinery development targets for 2025, such as Jiangsu aiming for a total power of 55 million kilowatts and Shandong targeting a comprehensive mechanization rate of 92% for crop farming [12][14] - Other provinces, like Zhejiang and Guangdong, have established ambitious mechanization rates for specific agricultural sectors, indicating a strong regional commitment to enhancing agricultural productivity through mechanization [14]

Group 1 - Double-Helix Pharmaceutical announced that its associate, Changfeng Pharmaceutical, is expected to be listed on the Hong Kong Stock Exchange on October 8, 2025, with a global offering of 41.198 million shares priced at HKD 14.75 each. Double-Helix holds approximately 3.68% of Changfeng's shares, with a lock-up period of 12 months post-listing [1] - Changfeng Pharmaceutical is involved in the pharmaceutical industry, specifically in the research and development of gene-engineered drugs [2] Group 2 - Lio Corporation has submitted an application to the Hong Kong Stock Exchange for issuing H-shares and listing on the main board [3] - Lio Corporation operates in the mechanical manufacturing and digital marketing sectors [3] Group 3 - Changjiang Securities received approval from the China Securities Regulatory Commission to issue corporate bonds totaling no more than CNY 20 billion, valid for 24 months [4] - Changjiang Securities provides services such as securities and futures brokerage, financial product distribution, investment advisory, asset custody, and margin financing [4] Group 4 - Jingye Intelligent plans to acquire 51% of Hefei Shengwen Information Technology for CNY 108 million, focusing on engineering information technology and intelligent products [5][6] - Jingye Intelligent specializes in the research, development, production, and sales of special robots and intelligent equipment systems [6] Group 5 - Aimeike's subsidiary received approval for the registration of Minoxidil topical solution, a non-prescription drug for treating hair loss [7][8] - Aimeike is engaged in the research, development, production, and sales of biomedical materials and biopharmaceuticals [8] Group 6 - Dalian Heavy Industry expects a net profit of CNY 474 million to CNY 508 million for the first three quarters of 2025, representing a year-on-year increase of 19.91% to 28.52% [9] - Dalian Heavy Industry specializes in the design, manufacturing, assembly, and installation of major technical equipment [9] Group 7 - Huayou Cobalt signed supply agreements with LGES for a total of approximately 76,000 tons of ternary precursor products from 2026 to 2030 [10][11] - Huayou Cobalt focuses on the research, manufacturing, and sales of new energy lithium battery materials and cobalt new materials [11] Group 8 - Zhenjiang Co. plans to reduce its shareholding by up to 5.529 million shares, not exceeding 3% of the total share capital, due to personal funding needs [12] - Zhenjiang Co. is involved in the design, processing, and sales of wind power equipment and components [12] Group 9 - Watson Bio's subsidiary received a drug registration certificate for a 13-valent pneumococcal polysaccharide conjugate vaccine for children [14][15] - Watson Bio specializes in the research, development, production, and sales of human vaccines and biopharmaceuticals [15] Group 10 - Yikang Pharmaceutical's major shareholder plans to reduce holdings by up to 42 million shares, not exceeding 2.04% of the total share capital, due to personal funding needs [16] - Yikang Pharmaceutical is engaged in the production and sales of excipients, raw materials, finished drugs, and new energy materials [16] Group 11 - Sichuan Gold's shareholder plans to reduce holdings by up to 7.56 million shares, accounting for 1.80% of the total share capital [19] - Sichuan Gold focuses on the construction, mining, and sales of gold mines [19] Group 12 - Kangchen Pharmaceutical received approval for a clinical trial of an innovative drug for treating advanced esophageal squamous cell carcinoma [20][21] - Kangchen Pharmaceutical specializes in the manufacturing of chemical drug formulations [21] Group 13 - UCloud plans to repurchase shares worth between CNY 8 million and CNY 10 million for employee stock ownership plans [22] - UCloud provides cloud computing services centered on IT infrastructure [22] Group 14 - Woton Technology announced an adjustment to its share repurchase plan, raising the price cap to CNY 60 per share [24] - Woton Technology specializes in the research, manufacturing, and sales of separation membrane products [24] Group 15 - Five Continents Medical announced plans for shareholders to reduce holdings by up to 126,530 shares, accounting for 1.8606% of the total share capital [26] - Five Continents Medical focuses on the research, manufacturing, and sales of disposable sterile infusion medical devices [26] Group 16 - CIMC Group plans to repurchase A-shares with a total amount not exceeding CNY 5 billion [27] - CIMC Group specializes in logistics and energy equipment solutions [27] Group 17 - Zhifei Biological's subsidiary received a drug registration certificate for a trivalent influenza vaccine suitable for individuals aged 3 and above [29][30] - Zhifei Biological is involved in the research, development, production, and sales of vaccines and biological products [30]

Group 1 - Double-Crane Pharmaceutical's associate company, Changfeng Pharmaceutical, is expected to officially list on the Hong Kong Stock Exchange on October 8, 2025, with stock code 02652.HK [1] - After the completion of the offering, Double-Crane Pharmaceutical will hold a total of 15.1657 million shares in Changfeng Pharmaceutical, which is expected to account for 3.68% of the total shares after issuance [1] Group 2 - LEO Holdings has submitted an application to the Hong Kong Stock Exchange on September 29, 2025, for the issuance of overseas listed shares (H shares) and for listing on the main board of the Hong Kong Stock Exchange [1]

Core Viewpoint - The company, LEO Group (002131.SZ), has submitted an application for the issuance of overseas listed shares (H-shares) and for listing on the main board of the Hong Kong Stock Exchange on September 29, 2025 [1] Group 1 - The application was submitted to the Hong Kong Stock Exchange and is in compliance with the requirements set by the Hong Kong Securities and Futures Commission [1] - The application materials were published on the Hong Kong Stock Exchange's website on the same day [1] - The submitted materials are in draft form and may be updated and revised as necessary [1]

Core Viewpoint - The company, Liao Group (002131), has submitted an application for the issuance of overseas listed shares (H shares) and for listing on the main board of the Hong Kong Stock Exchange on September 29, 2025 [1] Group 1 - The application materials for the issuance and listing were published on the Hong Kong Stock Exchange's website on the same day [1]

Core Viewpoint - The company, Leo Holdings (002131.SZ), has submitted an application for the issuance of overseas listed shares (H shares) and for listing on the main board of the Hong Kong Stock Exchange on September 29, 2025 [1] Group 1 - The application materials for this issuance and listing have been published on the Hong Kong Stock Exchange website on the same day [1]

证券代码：002131 证券简称：利欧股份 公告编号：2025-058 利欧集团股份有限公司 关于向香港联交所递交境外上市股份（H 股）发行上市申请 并刊发申请资料的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 利欧集团股份有限公司 利欧集团股份有限公司（以下简称"公司"）已于2025年9月29日向香港联合交 易所有限公司（以下简称"香港联交所"）递交了发行境外上市股份（H股）并在香 港联交所主板挂牌上市（以下简称"本次发行上市"）的申请，并于同日在香港联 交所网站刊登了本次发行上市的申请材料。该申请材料为公司按照香港证券及期货 事务监察委员会（以下简称"香港证监会"）及香港联交所的要求编制和刊发，为 草拟版本，其所载资料可能会适时作出更新及修订。 公司本次发行上市尚需取得中国证券监督管理委员会、香港证监会、香港联交 所等相关政府部门、监管机构、证券交易所的批准或备案，并需综合考虑市场情况 以及其他因素方可实施，该事项仍存在不确定性。公司将根据相关事项的进展情况， 严格按照相关法律法规的规定与要求，及时履行信息披露义务，敬请广大投资者注 意投资风险。 ...